array(40) {
  [0]=>
  string(4) "8983"
  ["article_id"]=>
  string(4) "8983"
  [1]=>
  string(118) "I’ve been accused of abusing sick leave when I have coronavirus symptoms, joking about age and weight, and more"
  ["article_title"]=>
  string(118) "I’ve been accused of abusing sick leave when I have coronavirus symptoms, joking about age and weight, and more"
  [2]=>
  string(164) "It’s five answers to five questions. Here we go… 1. I’ve been accused of abusing sick leave when I have coronavirus symptoms I work as a lab tec"
  ["short_description"]=>
  string(164) "It’s five answers to five questions. Here we go… 1. I’ve been accused of abusing sick leave when I have coronavirus symptoms I work as a lab tec"
  [3]=>
  string(1719) "
It’s five answers to five questions. Here we go… 1. I’ve been accused of abusing sick leave when I have coronavirus symptoms I work as a lab tech for a hospital that employees tens of thousands of people and I’m essential and cannot work from home. I experienced shortness of breath a while back so […]
&#nl
&#nl
You may also like:
&#nl
&#nl
we have a new paid (paid!) sick and family leave law
&#nl
how do you deal with professional insults followed by with "I'm just kidding"?
&#nl
coworkers only ask me about ducks, adult facts in a work presentation, and more
&#nl
&#nl
&#nl
&#nl
I’ve been accused of abusing sick leave when I have coronavirus symptoms, joking about age and weight, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  ["description"]=>
  string(1719) "
It’s five answers to five questions. Here we go… 1. I’ve been accused of abusing sick leave when I have coronavirus symptoms I work as a lab tech for a hospital that employees tens of thousands of people and I’m essential and cannot work from home. I experienced shortness of breath a while back so […]
&#nl
&#nl
You may also like:
&#nl
&#nl
we have a new paid (paid!) sick and family leave law
&#nl
how do you deal with professional insults followed by with "I'm just kidding"?
&#nl
coworkers only ask me about ducks, adult facts in a work presentation, and more
&#nl
&#nl
&#nl
&#nl
I’ve been accused of abusing sick leave when I have coronavirus symptoms, joking about age and weight, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "5"
  ["category"]=>
  string(1) "5"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "50"
  ["rss_id"]=>
  string(2) "50"
  [14]=>
  string(149) "https://www.askamanager.org/2020/04/ive-been-accused-of-abusing-sick-leave-when-i-have-coronavirus-symptoms-joking-about-age-and-weight-and-more.html"
  ["blog_url"]=>
  string(149) "https://www.askamanager.org/2020/04/ive-been-accused-of-abusing-sick-leave-when-i-have-coronavirus-symptoms-joking-about-age-and-weight-and-more.html"
  [15]=>
  string(19) "2020-04-02 12:03:09"
  ["add_date"]=>
  string(19) "2020-04-02 12:03:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:25"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8869"
  ["article_id"]=>
  string(4) "8869"
  [1]=>
  string(116) "CooperCompanies Announces $2.14 Billion Senior Credit Facility and Amendment of $500 Million 364-Day Credit Facility"
  ["article_title"]=>
  string(116) "CooperCompanies Announces $2.14 Billion Senior Credit Facility and Amendment of $500 Million 364-Day Credit Facility"
  [2]=>
  string(150) "SAN RAMON, Calif., April  01, 2020  (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced the closing of a new five-year $2.14 billion senior"
  ["short_description"]=>
  string(150) "SAN RAMON, Calif., April  01, 2020  (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced the closing of a new five-year $2.14 billion senior"
  [3]=>
  string(949) "
SAN RAMON, Calif., April  01, 2020  (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced the closing of a new five-year $2.14 billion senior unsecured credit facility, comprised of a $1.29 billion revolving line of credit and $850 million non-amortizing term loan. Proceeds from the refinancing will be used to retire all indebtedness under the Company’s existing $1.0 billion revolving line of credit and $1.0 billion term loan, as well as for general corporate purposes. The borrowing rates will be based on the Company’s leverage ratio, as defined in the Credit Agreement, and can range from LIBOR plus 0.75 percent to 1.5 percent. The initial borrowing rate is LIBOR plus 0.875 percent, which is 25 bps lower than the Company’s current borrowing rate. The Company also announced an amendment to its $500 million 364-day credit facility to match terms and conditions of the new facility where applicable. 
"
  ["description"]=>
  string(949) "
SAN RAMON, Calif., April  01, 2020  (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced the closing of a new five-year $2.14 billion senior unsecured credit facility, comprised of a $1.29 billion revolving line of credit and $850 million non-amortizing term loan. Proceeds from the refinancing will be used to retire all indebtedness under the Company’s existing $1.0 billion revolving line of credit and $1.0 billion term loan, as well as for general corporate purposes. The borrowing rates will be based on the Company’s leverage ratio, as defined in the Credit Agreement, and can range from LIBOR plus 0.75 percent to 1.5 percent. The initial borrowing rate is LIBOR plus 0.875 percent, which is 25 bps lower than the Company’s current borrowing rate. The Company also announced an amendment to its $500 million 364-day credit facility to match terms and conditions of the new facility where applicable. 
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(185) "http://www.globenewswire.com/news-release/2020/04/01/2010290/0/en/CooperCompanies-Announces-2-14-Billion-Senior-Credit-Facility-and-Amendment-of-500-Million-364-Day-Credit-Facility.html"
  ["blog_url"]=>
  string(185) "http://www.globenewswire.com/news-release/2020/04/01/2010290/0/en/CooperCompanies-Announces-2-14-Billion-Senior-Credit-Facility-and-Amendment-of-500-Million-364-Day-Credit-Facility.html"
  [15]=>
  string(19) "2020-04-02 04:15:00"
  ["add_date"]=>
  string(19) "2020-04-02 04:15:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:04"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9006"
  ["article_id"]=>
  string(4) "9006"
  [1]=>
  string(57) "Indiana-Based Primex Plastics Producing Materials for PPE"
  ["article_title"]=>
  string(57) "Indiana-Based Primex Plastics Producing Materials for PPE"
  [2]=>
  string(158) "&#nl        RICHMOND, IN — Primex Plastics Corporation has dedicated its three divisions to producing vital materials for first responders and medical "
  ["short_description"]=>
  string(158) "&#nl        RICHMOND, IN — Primex Plastics Corporation has dedicated its three divisions to producing vital materials for first responders and medical "
  [3]=>
  string(209) "&#nl        RICHMOND, IN — Primex Plastics Corporation has dedicated its three divisions to producing vital materials for first responders and medical professionals in New Jersey and Indiana. &#nl      "
  ["description"]=>
  string(209) "&#nl        RICHMOND, IN — Primex Plastics Corporation has dedicated its three divisions to producing vital materials for first responders and medical professionals in New Jersey and Indiana. &#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(100) "https://www.assemblymag.com/articles/95608-indiana-based-primex-plastics-producing-materials-for-ppe"
  ["blog_url"]=>
  string(100) "https://www.assemblymag.com/articles/95608-indiana-based-primex-plastics-producing-materials-for-ppe"
  [15]=>
  string(19) "2020-04-02 00:52:52"
  ["add_date"]=>
  string(19) "2020-04-02 00:52:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:50"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8805"
  ["article_id"]=>
  string(4) "8805"
  [1]=>
  string(88) "Emergency funding for COVID-19 not enough to prevent pharmacy closures, trade body warns"
  ["article_title"]=>
  string(88) "Emergency funding for COVID-19 not enough to prevent pharmacy closures, trade body warns"
  [2]=>
  string(152) "Emergency COVID-19 funding for community pharmacies may not be enough to prevent closures, pharmacy bodies have said, after the government promised £"
  ["short_description"]=>
  string(152) "Emergency COVID-19 funding for community pharmacies may not be enough to prevent closures, pharmacy bodies have said, after the government promised £"
  [3]=>
  string(192) "Emergency COVID-19 funding for community pharmacies may not be enough to prevent closures, pharmacy bodies have said, after the government promised £300m in advance payments for pharmacies."
  ["description"]=>
  string(192) "Emergency COVID-19 funding for community pharmacies may not be enough to prevent closures, pharmacy bodies have said, after the government promised £300m in advance payments for pharmacies."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(166) "https://www.pharmaceutical-journal.com/news-and-analysis/news/emergency-funding-for-covid-19-not-enough-to-prevent-pharmacy-closures-trade-body-warns/20207869.article"
  ["blog_url"]=>
  string(166) "https://www.pharmaceutical-journal.com/news-and-analysis/news/emergency-funding-for-covid-19-not-enough-to-prevent-pharmacy-closures-trade-body-warns/20207869.article"
  [15]=>
  string(19) "2020-04-01 23:21:00"
  ["add_date"]=>
  string(19) "2020-04-01 23:21:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9011"
  ["article_id"]=>
  string(4) "9011"
  [1]=>
  string(60) "GE Healthcare Life Sciences completes transition into Cytiva"
  ["article_title"]=>
  string(60) "GE Healthcare Life Sciences completes transition into Cytiva"
  [2]=>
  string(154) "As Danaherâs $21bn acquisition completes, GE Life Sciences rebrands to âCytivaâ and, with the COVID-19 pandemic, its CEO tells us demand is high."
  ["short_description"]=>
  string(154) "As Danaherâs $21bn acquisition completes, GE Life Sciences rebrands to âCytivaâ and, with the COVID-19 pandemic, its CEO tells us demand is high."
  [3]=>
  string(154) "As Danaherâs $21bn acquisition completes, GE Life Sciences rebrands to âCytivaâ and, with the COVID-19 pandemic, its CEO tells us demand is high."
  ["description"]=>
  string(154) "As Danaherâs $21bn acquisition completes, GE Life Sciences rebrands to âCytivaâ and, with the COVID-19 pandemic, its CEO tells us demand is high."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(148) "https://www.biopharma-reporter.com/Article/2020/04/01/GE-Healthcare-Life-Sciences-becomes-Cytiva?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(148) "https://www.biopharma-reporter.com/Article/2020/04/01/GE-Healthcare-Life-Sciences-becomes-Cytiva?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-01 22:18:00"
  ["add_date"]=>
  string(19) "2020-04-01 22:18:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:55"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9000"
  ["article_id"]=>
  string(4) "9000"
  [1]=>
  string(125) "&#nlCOVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes, , 01/04/2020"
  ["article_title"]=>
  string(125) "&#nlCOVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes, , 01/04/2020"
  [2]=>
  string(168) "&#nl&#nl          &#nl              &#nl&#nl&#nlChloroquine and hydroxychloroquine, two medicines currently authorised for malaria and certain autoimmune diseases, are "
  ["short_description"]=>
  string(168) "&#nl&#nl          &#nl              &#nl&#nl&#nlChloroquine and hydroxychloroquine, two medicines currently authorised for malaria and certain autoimmune diseases, are "
  [3]=>
  string(199) "&#nl&#nl          &#nl              &#nl&#nl&#nlChloroquine and hydroxychloroquine, two medicines currently authorised for malaria and certain autoimmune diseases, are being investigated worldwide..."
  ["description"]=>
  string(199) "&#nl&#nl          &#nl              &#nl&#nl&#nlChloroquine and hydroxychloroquine, two medicines currently authorised for malaria and certain autoimmune diseases, are being investigated worldwide..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(128) "
https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes"
  ["blog_url"]=>
  string(128) "
https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes"
  [15]=>
  string(19) "2020-04-01 20:20:00"
  ["add_date"]=>
  string(19) "2020-04-01 20:20:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8791"
  ["article_id"]=>
  string(4) "8791"
  [1]=>
  string(72) "FDA Requests Removal of All Ranitidine Products (Zantac) From the Market"
  ["article_title"]=>
  string(72) "FDA Requests Removal of All Ranitidine Products (Zantac) From the Market"
  [2]=>
  string(150) "Audience: Patient, Health Professional, Pharmacy ISSUE:  The FDA announced it is requesting manufacturers to withdraw all prescription and over-t"
  ["short_description"]=>
  string(150) "Audience: Patient, Health Professional, Pharmacy ISSUE:  The FDA announced it is requesting manufacturers to withdraw all prescription and over-t"
  [3]=>
  string(254) "Audience: Patient, Health Professional, Pharmacy ISSUE:  The FDA announced it is requesting manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. &#nlThis is the latest step in an..."
  ["description"]=>
  string(254) "Audience: Patient, Health Professional, Pharmacy ISSUE:  The FDA announced it is requesting manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. &#nlThis is the latest step in an..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(215) "https://www.drugs.com/fda/fda-requests-removal-all-ranitidine-products-zantac-market-14356.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Requests+Removal+of+All+Ranitidine+Products+%28Zantac%29+From+the+Market"
  ["blog_url"]=>
  string(215) "https://www.drugs.com/fda/fda-requests-removal-all-ranitidine-products-zantac-market-14356.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Requests+Removal+of+All+Ranitidine+Products+%28Zantac%29+From+the+Market"
  [15]=>
  string(19) "2020-04-01 20:00:00"
  ["add_date"]=>
  string(19) "2020-04-01 20:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:38"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9001"
  ["article_id"]=>
  string(4) "9001"
  [1]=>
  string(82) "&#nlRegulatory information - 1.6% increase in fees from 1 April 2020, , 01/04/2020"
  ["article_title"]=>
  string(82) "&#nlRegulatory information - 1.6% increase in fees from 1 April 2020, , 01/04/2020"
  [2]=>
  string(159) "&#nl&#nl          &#nl              General, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders are increasing by 1.6%"
  ["short_description"]=>
  string(159) "&#nl&#nl          &#nl              General, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders are increasing by 1.6%"
  [3]=>
  string(191) "&#nl&#nl          &#nl              General, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders are increasing by 1.6% on 1 April 2020.Full details..."
  ["description"]=>
  string(191) "&#nl&#nl          &#nl              General, non-pharmacovigilance fees payable to EMA by applicants and marketing-authorisation holders are increasing by 1.6% on 1 April 2020.Full details..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(87) "
https://www.ema.europa.eu/en/news/regulatory-information-16-increase-fees-1-april-2020"
  ["blog_url"]=>
  string(87) "
https://www.ema.europa.eu/en/news/regulatory-information-16-increase-fees-1-april-2020"
  [15]=>
  string(19) "2020-04-01 19:40:00"
  ["add_date"]=>
  string(19) "2020-04-01 19:40:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8986"
  ["article_id"]=>
  string(4) "8986"
  [1]=>
  string(39) "From Adversity Comes Opportunity For HR"
  ["article_title"]=>
  string(39) "From Adversity Comes Opportunity For HR"
  [2]=>
  string(158) "“Every adversity contains, at the same time, a seed of equivalent opportunity”. One of many quotes from the controversial Napoleon Hill, an Americ"
  ["short_description"]=>
  string(158) "“Every adversity contains, at the same time, a seed of equivalent opportunity”. One of many quotes from the controversial Napoleon Hill, an Americ"
  [3]=>
  string(828) "
“Every adversity contains, at the same time, a seed of equivalent opportunity”. One of many quotes from the controversial Napoleon Hill, an American Self-help author from the early 20th century. I know your probably saying – Mark where did that come from? No, I did not go to my “go to guy” at Fistful of Talent, Paul Herbert, for the ... 
&#nl
Read More
&#nl
The post From Adversity Comes Opportunity For HR appeared first on Fistful of Talent.
&#nl"
  ["description"]=>
  string(828) "
“Every adversity contains, at the same time, a seed of equivalent opportunity”. One of many quotes from the controversial Napoleon Hill, an American Self-help author from the early 20th century. I know your probably saying – Mark where did that come from? No, I did not go to my “go to guy” at Fistful of Talent, Paul Herbert, for the ... 
&#nl
Read More
&#nl
The post From Adversity Comes Opportunity For HR appeared first on Fistful of Talent.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "4"
  ["category"]=>
  string(1) "4"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "52"
  ["rss_id"]=>
  string(2) "52"
  [14]=>
  string(106) "http://feedproxy.google.com/~r/FistfulOfTalent/~3/IBO2uQFzgVQ/from-adversity-comes-opportunity-for-hr.html"
  ["blog_url"]=>
  string(106) "http://feedproxy.google.com/~r/FistfulOfTalent/~3/IBO2uQFzgVQ/from-adversity-comes-opportunity-for-hr.html"
  [15]=>
  string(19) "2020-04-01 19:28:00"
  ["add_date"]=>
  string(19) "2020-04-01 19:28:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:25"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8806"
  ["article_id"]=>
  string(4) "8806"
  [1]=>
  string(105) "More lifestyle support needed for patients starting medicines for cardiovascular disease, study concludes"
  ["article_title"]=>
  string(105) "More lifestyle support needed for patients starting medicines for cardiovascular disease, study concludes"
  [2]=>
  string(150) "People who initiate statins or antihypertensive medicines are more likely to become obese or physically inactive compared with people who do not, a st"
  ["short_description"]=>
  string(150) "People who initiate statins or antihypertensive medicines are more likely to become obese or physically inactive compared with people who do not, a st"
  [3]=>
  string(232) "People who initiate statins or antihypertensive medicines are more likely to become obese or physically inactive compared with people who do not, a study published in the Journal of the American Heart Association suggests. "
  ["description"]=>
  string(232) "People who initiate statins or antihypertensive medicines are more likely to become obese or physically inactive compared with people who do not, a study published in the Journal of the American Heart Association suggests. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(196) "https://www.pharmaceutical-journal.com/news-and-analysis/research-briefing/more-lifestyle-support-needed-for-patients-starting-medicines-for-cardiovascular-disease-study-concludes/20207810.article"
  ["blog_url"]=>
  string(196) "https://www.pharmaceutical-journal.com/news-and-analysis/research-briefing/more-lifestyle-support-needed-for-patients-starting-medicines-for-cardiovascular-disease-study-concludes/20207810.article"
  [15]=>
  string(19) "2020-04-01 19:20:00"
  ["add_date"]=>
  string(19) "2020-04-01 19:20:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9002"
  ["article_id"]=>
  string(4) "9002"
  [1]=>
  string(87) "&#nlEU recommendations for 2020/2021 seasonal flu vaccine composition, CHMP, 01/04/2020"
  ["article_title"]=>
  string(87) "&#nlEU recommendations for 2020/2021 seasonal flu vaccine composition, CHMP, 01/04/2020"
  [2]=>
  string(159) "&#nl&#nl          &#nl              EMA has issued the recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines fo"
  ["short_description"]=>
  string(159) "&#nl&#nl          &#nl              EMA has issued the recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines fo"
  [3]=>
  string(190) "&#nl&#nl          &#nl              EMA has issued the recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal..."
  ["description"]=>
  string(190) "&#nl&#nl          &#nl              EMA has issued the recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(95) "
https://www.ema.europa.eu/en/news/eu-recommendations-20202021-seasonal-flu-vaccine-composition"
  ["blog_url"]=>
  string(95) "
https://www.ema.europa.eu/en/news/eu-recommendations-20202021-seasonal-flu-vaccine-composition"
  [15]=>
  string(19) "2020-04-01 19:00:00"
  ["add_date"]=>
  string(19) "2020-04-01 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8959"
  ["article_id"]=>
  string(4) "8959"
  [1]=>
  string(29) "NSAI named as a notified body"
  ["article_title"]=>
  string(29) "NSAI named as a notified body"
  [2]=>
  string(134) "National Standards Authority of Ireland (NSAI) was awarded Notified Body (NB) status under the new EU Medical Device Regulation (MDR)."
  ["short_description"]=>
  string(134) "National Standards Authority of Ireland (NSAI) was awarded Notified Body (NB) status under the new EU Medical Device Regulation (MDR)."
  [3]=>
  string(134) "National Standards Authority of Ireland (NSAI) was awarded Notified Body (NB) status under the new EU Medical Device Regulation (MDR)."
  ["description"]=>
  string(134) "National Standards Authority of Ireland (NSAI) was awarded Notified Body (NB) status under the new EU Medical Device Regulation (MDR)."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(71) "https://www.medicalplasticsnews.com/news/nsai-named-as-a-notified-body/"
  ["blog_url"]=>
  string(71) "https://www.medicalplasticsnews.com/news/nsai-named-as-a-notified-body/"
  [15]=>
  string(19) "2020-04-01 18:19:43"
  ["add_date"]=>
  string(19) "2020-04-01 18:19:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}